The arrival of BrightMeds GLP-1 marks a vital shift in how physicians manage type 2 diabetes . This novel medication type offers a different way of working that and decreases sugar but can facilitate weight loss and improve cardiovascular outcomes. Early data suggest it could be a a valuable reso